Significant advancements in biotechnology have resulted in the development of numerous fundamental bioprocesses, which have consolidated research and development and industrial progress in the field. These bioprocesses are used in medical therapies, diagnostic and immunization procedures, agriculture, food production, biofuel production, and environmental solutions (to address water-, soil-, and air-related problems), among other areas. The present study is a first approach toward the identification of scientific and technological bioprocess trajectories within the framework of sustainability. The method included a literature search (Scopus), a patent search (Patentscope), and a network analysis for the period from 2010 to 2019. Our results highlight the main technological sectors, countries, institutions, and academic publications that carry out work or publish literature related to sustainability and bioprocesses. The network analysis allowed for the identification of thematic clusters associated with sustainability and bioprocesses, revealing different related scientific topics. Our conclusions confirm that biotechnology is firmly positioned as an emerging knowledge area. Its dynamics, development, and outcomes during the study period reflect a substantial number of studies and technologies focused on the creation of knowledge aimed at improving economic development, environmental protection, and social welfare.
Purpose
Transgenic crops have been increasingly adopted, produced and commercialized throughout the world. Correspondingly, the management of intellectual property rights concerning transgenic crops has gained importance. In this context, it is necessary to understand the status quo of transgenic crop production, especially in developing countries. The purpose of this paper is to provide a general scenario of transgenic crops and their growth around the world, especially in Latin America.
Design/methodology/approach
A literature review was carried out to determine the status of intellectual property protection, production and commercialization of transgenic crops.
Findings
Opinions concerning the risks and benefits of adopting transgenics are markedly divided. Its presence in the agricultural sector has undoubtedly taken a firm hold in different parts of the world. Nevertheless, there are some areas of the international transgenics industry that need further and ongoing discussion and assessment, such as biosafety, intellectual property, regulation and legislation, among others. Additionally, in developing countries, and especially in the case of Latin America, other relevant issues to be addressed are associated with the conservation of local plant varieties and the preservation of cultural values, as well as the development of endogenous technology to solve local problems and the integration of farmers and the society at large and their interests into the discussion.
Research limitations/implications
The most significant limitation of the present study was the lack of available data. Future studies using larger data sets will allow for more robust statistical analyses. Additionally, country-specific studies focused on the most important crops, those that each country grows intensively, are necessary for a better insight into the global dynamics of the sector; these studies must stress the intellectual property mechanisms used and address biosafety and regulatory issues, among other areas.
Originality/value
The present study represents a starting point for establishing schemes to facilitate the proper development and management of transgenic technology based on regional interests and the guiding principles of ethics and biosecurity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.